Poster

Comparative Evaluation of Automated and Conventional Flow Cytometry Methods for Leukapheresis Characterization Upon Cryopreservation Process

Leukapheresis products stand at the foundation of cell and gene therapy manufacturing, serving as critical starting materials whose cellular composition shapes both process performance and clinical outcomes. Cryopreservation has opened the door to more flexible, decentralized workflows, yet it still suffers from a lack of standardized methods for robust sample characterization.

This poster compares performance of conventional flow cytometry and automated platforms using cryopreserved leukapheresis and explores how:

• The IntegriCell© Automated Close Cryopreservation Process (ACP) reduces operational risk and cost while safeguarding cell viability
• The use of the Accellix™ Platform streamlines and standardize flow cytometry workflows

Learn how combining these two innovative automated processes simplify and accelerate technology transfers and increase operational consistency under GMP-relevant conditions.